BSECompany Update30 Sept 2026 · 30 Sept 2026, 12:21 pm

Submission of Disclosures under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 - Off Market transfer of equity shares

Amanta Healthcare Ltd · 544502

✦ AI SummaryRegulatory

Amanta Healthcare Ltd submitted disclosures under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, regarding an off-market transfer of equity shares. The company received the declaration from two members of the promoter group.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk1/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Amanta Healthcare Ltd - 544502 - Submission Of Disclosures Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015 - Off Market Transfer Of Equity Shares

Attachments (1)

📄

d9c274a4-8a60-4316-a7af-10721a715216.pdf

pdf

Download →
View document text
Registered & Corporate Office: AMANTA HEALTHCARE LIMITED 8th Floor, Shaligram Corporates, CJ Marg, Ambli, Ahmedabad–380058, Gujarat, INDIA. Tel.: 079 – 67777600 Email: info@amanta.co.in Website: www.amanta.co.in CIN: L24139GJ1994PLC023944 Date: September 30, 2026 To, To, Sr. General Manager Sr. General Manager Listing Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G Phiroze Jeejeebhoy Towers, Bandra Kurla Complex Dalal Street, Mumbai – 400 001. Bandra (E), Mumbai – 400 051. Scrip Code: 544502 Trading Symbol: AMANTA Dear Sir / Madam, Sub.: Submission of Disclosures under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 (the “Insider Trading Regulations”) Off-Market Transaction of Equity Shares With reference to the subject cited above, the Company has received the declaration under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. Please find enclosed herewith the disclosures in Form “C” as received from Shri Pravinchandra Dhanjibhai Mehta and Shri Kirit Ambalal Desai, Members of Promoter Group of the Company. You are requested to take the same on records and acknowledge the receipt of the same. Thanking you, Yours faithfully, FOR, AMANTA HEALTHCARE LIMITED NIKHITA DINODIA COMPANY SECRETARY & COMPLIANCE OFFICER Enclosed: as above Factory: 876, N.H. No. 8, Hariyala, Kheda – 387411, Gujarat, India. Tel 2694287700 Fax 2694287720